ELEVATION ONCOLOGY INC's ticker is ELEV and the CUSIP is 28623U101. A total of 28 filers reported holding ELEVATION ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 2,834,910 | $38,470,000 | 6.16% |
| venBio Partners LLC | 2,608,167 | $35,393,000 | 4.18% |
| Samsara BioCapital, LLC | 932,239 | $12,650,000 | 1.56% |
| Cormorant Asset Management, LP | 1,983,165 | $25,566,000 | 0.87% |
| BVF INC/IL | 1,590,291 | $21,580,000 | 0.81% |
| Boxer Capital, LLC | 1,341,530 | $18,205,000 | 0.64% |
| Ghost Tree Capital, LLC | 100,000 | $1,357,000 | 0.37% |
| CAXTON CORP | 39,586 | $537,000 | 0.37% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,999,514 | $26,456,000 | 0.35% |
| Vivo Capital, LLC | 496,843 | $6,742,000 | 0.29% |